Form D · Biotechnology
Olive Medical Corp
Sandy, UT · CIK 0001476058
Offering snapshot reported Nov 28, 2011 · SEC filing
- Reported sold
- $1M Indefinite offering
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Oct 18, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 28, 2011 | Initial | $1,000,000 | No comparison | 17 | SEC filing |
| Dec 10, 2010 | Amendment | $871,500 | $383,000vs Nov 17, 2010 | 20 | SEC filing |
| Nov 17, 2010 | Initial | $488,500 | No comparison | 13 | SEC filing |
| Nov 4, 2009 | Initial | $200,000 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-169292
Source: Form D, filed Nov 28, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Laurant Blanquart | Executive |
| J. Michael Brown | Director |
| Milton Drake | Director, Executive |
| Jeremiah Henley | Executive |
| Dann Hughes | Director |
| S. George Simon | Director |
| Joshua Talbert | Director, Executive |
| Curtis Wichern | Executive |
| Donald Wichern | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
9690 South 300 West Suite 320 H
Sandy, UT, 84070
Sandy, UT, 84070